Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yaa-Hui Dong

Showing results (21-30 of 49) with videos related to

Pageof 5
Sort By:
BMJ (Clinical Research Ed.)|October 4, 2016
Risk of mortality with concomitant use of tamoxifen and selective serotonin reuptake inhibitors: multi-database cohort studyMacarius M Donneyong, Katsiaryna Bykov, Pauline Bosco-Levy, et al.
BMC Veterinary Research|January 28, 2012
Relationship of orthopedic examination, goniometric measurements, and radiographic signs of degenerative joint disease in catsB Duncan X Lascelles, Yaa-Hui Dong, Denis J Marcellin-Little, et al.
JAMA Internal Medicine|September 8, 2020
Association of Infections and Use of Fluoroquinolones With the Risk of Aortic Aneurysm or Aortic DissectionYaa-Hui Dong, Chia-Hsuin Chang, Jiun-Ling Wang, et al.
International Journal of Clinical Pharmacy|November 7, 2025
Comparative effectiveness and safety of fluticasone-based versus beclometasone-based single-inhaler triple therapies in patients with chronic obstructive pulmonary disease: a population-based cohort studyYaa-Hui Dong, Sheng-Wei Pan, Ming-Ching Chen, et al.
Peerj|February 19, 2024
Risk of circulatory diseases associated with proton-pump inhibitors: a retrospective cohort study using electronic medical records in ThailandTanavij Pannoi, Chissanupong Promchai, Penjamaporn Apiromruck, et al.
Respiratory Research|September 29, 2023
Comparative cardiovascular safety of LABA/LAMA FDC versus LABA/ICS FDC in patients with chronic obstructive pulmonary disease: a population-based cohort study with a target trial emulation frameworkChun-Yu Chen, Sheng-Wei Pan, Chia-Chen Hsu, et al.
Pharmacotherapy|May 4, 2022
Association between glucagon-like peptide-1 receptor agonists and biliary-related diseases in patients with type 2 diabetes: A nationwide cohort studyYaa-Hui Dong, Jo-Hsuan Wu, Chia-Hsuin Chang, et al.
Diabetes, Obesity & Metabolism|May 2, 2022
Comparative cardiovascular effectiveness of glucagon-like peptide-1 receptor agonists versus sodium-glucose cotransporter-2 inhibitors in patients with type 2 diabetes: A population-based cohort studyYaa-Hui Dong, Chia-Hsuin Chang, Jou-Wei Lin, et al.
Pharmacotherapy|February 7, 2013
Development and validation of a pharmacy-based comorbidity measure in a population-based automated health care databaseYaa-Hui Dong, Chia-Hsuin Chang, Wen-Yi Shau, et al.
Plos Medicine|September 14, 2019
Incidence of hospitalization for infection among patients with hepatitis B or C virus infection without cirrhosis in Taiwan: A cohort studyYen-Chieh Lee, Jiun-Ling Wang, Yaa-Hui Dong, et al.
Pageof 5

Showing results (21-30 of 49) with videos related to

Sort By:
Pageof 5
BMJ (Clinical Research Ed.)|October 4, 2016
Risk of mortality with concomitant use of tamoxifen and selective serotonin reuptake inhibitors: multi-database cohort studyMacarius M Donneyong, Katsiaryna Bykov, Pauline Bosco-Levy, et al.
BMC Veterinary Research|January 28, 2012
Relationship of orthopedic examination, goniometric measurements, and radiographic signs of degenerative joint disease in catsB Duncan X Lascelles, Yaa-Hui Dong, Denis J Marcellin-Little, et al.
JAMA Internal Medicine|September 8, 2020
Association of Infections and Use of Fluoroquinolones With the Risk of Aortic Aneurysm or Aortic DissectionYaa-Hui Dong, Chia-Hsuin Chang, Jiun-Ling Wang, et al.
International Journal of Clinical Pharmacy|November 7, 2025
Comparative effectiveness and safety of fluticasone-based versus beclometasone-based single-inhaler triple therapies in patients with chronic obstructive pulmonary disease: a population-based cohort studyYaa-Hui Dong, Sheng-Wei Pan, Ming-Ching Chen, et al.
Peerj|February 19, 2024
Risk of circulatory diseases associated with proton-pump inhibitors: a retrospective cohort study using electronic medical records in ThailandTanavij Pannoi, Chissanupong Promchai, Penjamaporn Apiromruck, et al.
Respiratory Research|September 29, 2023
Comparative cardiovascular safety of LABA/LAMA FDC versus LABA/ICS FDC in patients with chronic obstructive pulmonary disease: a population-based cohort study with a target trial emulation frameworkChun-Yu Chen, Sheng-Wei Pan, Chia-Chen Hsu, et al.
Pharmacotherapy|May 4, 2022
Association between glucagon-like peptide-1 receptor agonists and biliary-related diseases in patients with type 2 diabetes: A nationwide cohort studyYaa-Hui Dong, Jo-Hsuan Wu, Chia-Hsuin Chang, et al.
Diabetes, Obesity & Metabolism|May 2, 2022
Comparative cardiovascular effectiveness of glucagon-like peptide-1 receptor agonists versus sodium-glucose cotransporter-2 inhibitors in patients with type 2 diabetes: A population-based cohort studyYaa-Hui Dong, Chia-Hsuin Chang, Jou-Wei Lin, et al.
Pharmacotherapy|February 7, 2013
Development and validation of a pharmacy-based comorbidity measure in a population-based automated health care databaseYaa-Hui Dong, Chia-Hsuin Chang, Wen-Yi Shau, et al.
Plos Medicine|September 14, 2019
Incidence of hospitalization for infection among patients with hepatitis B or C virus infection without cirrhosis in Taiwan: A cohort studyYen-Chieh Lee, Jiun-Ling Wang, Yaa-Hui Dong, et al.
Pageof 5